Trials / Completed
CompletedNCT02479529
Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
After cardiac surgery, vasoplegic syndrome is a hemodynamic state characterized by profound hypotension associated with a decrease in systemic vascular resistance. The care of this disease is based on the intravenous administration of a vasopressor, usually norepinephrine. During the recovery phase, weaning of norepinephrine, is an important step in which any lack of preload (blood volume) initial or secondary can be, and increase tissue malperfusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine | Administration and weaning of norepinephrine is based on dynamic arterial elastance |
| DRUG | Norepinephrine | The usual procedure of withdrawal norepinephrine is based on hemodynamic parameters (blood pressure, cardiac output), clinical (cutaneous perfusion, mottling, hourly diuresis) and biological (SVO2, arterial lactate). |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-06-24
- Last updated
- 2025-09-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02479529. Inclusion in this directory is not an endorsement.